$PLX Headlines In focus: Awaiting the next mov
Post# of 88933
Posted On: 10/13/2014 1:50:39 PM
$PLX Headlines
In focus: Awaiting the next move 8:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Using Plants to Make Cheaper Biotech Drugs 10:41 a.m. July 9, 2012 - MarketWatch
Wells Fargo cuts Protalix to market perform 9:11 a.m. June 25, 2012 - Greg Morcroft
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
Wednesday’s biggest gaining and declining stocks 4:47 p.m. May 2, 2012 - MarketWatch
Protalix, Formfactor, Opentable see options volume surge 12:20 p.m. May 2, 2012 - blogs.marketwatch.com
Canaccord cuts Protalix to hold from buy 9:17 a.m. May 2, 2012 - Greg Morcroft
Genworth rises, Chesapeake falls after hours 5:24 p.m. May 1, 2012 - Myra P. Saefong
American Capital options volume surges 10:48 a.m. May 1, 2012 - blogs.marketwatch.com
Protalix prices shares at 14% discount 11:51 a.m. Feb. 16, 2012 - MarketWatch.com
Tuesday’s biggest gaining & declining stocks 5:48 p.m. Dec. 6, 2011 - Kate Gibson
Protalix shares riae 4.6% in preopen trade 8:58 a.m. Aug. 17, 2011 - Greg Morcroft
FDA accepts Protalix resubmission for Gaucher drug 8:57 a.m. Aug. 17, 2011 - MarketWatch.com
Israel stocks lower; Ness agrees to takeover 8:56 a.m. June 12, 2011 - Robert Daniel
Israel stocks fall after central bank’s rate hike 9:12 a.m. May 24, 2011 - Robert Daniel
Israel stocks edge higher, lifted by energy sector 11:12 a.m. May 19, 2011 - Robert Daniel
Israel stocks advance, led by finance, property 7:32 a.m. March 21, 2011 - Robert Daniel
Israel up as Strauss, Migdal, Gazit-Globe report 9:20 a.m. March 16, 2011 - Robert Daniel
Israel stocks lower; Prolor and Protalix ease 8:51 a.m. March 6, 2011 - Robert Daniel
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy
Ebola traders need to rest 10:52 a.m. Today - Seeking Alpha
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 8:12 a.m. Oct. 3, 2014 - Seeking Alpha
How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape 8:42 a.m. Sept. 26, 2014 - Zacks.com
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog 3:12 p.m. Sept. 5, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape 9:11 a.m. Aug. 29, 2014 - Zacks.com
InsiderInsights.com Daily Round Up: 8/15/14 3:06 a.m. Aug. 17, 2014 - Seeking Alpha
Facebook Leads 3 High-Volume Young Gun Stock Leaders 6:14 p.m. June 24, 2014 - Investors Business Daily
Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog 6:15 p.m. June 19, 2014 - Zacks.com
Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape 9:25 a.m. June 19, 2014 - Zacks.com
Protalix commences Phase 2a Gaucher trial 9:01 a.m. June 18, 2014 - Seeking Alpha
Protalix chief to retire 9:25 a.m. June 13, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
10-Q: PROTALIX BIOTHERAPEUTICS, INC. 4:36 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Relative Strength Alert For Protalix BioTherapeutics 12:22 p.m. April 25, 2014 - TheStreet.com
Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology 12:33 p.m. Feb. 13, 2014 - Seeking Alpha
24/7 suggests eight biotech trading near $5 with big upside potential 9:25 a.m. Feb. 8, 2014 - Seeking Alpha
Protalix provides 2014 outlook, shares rise 10:07 a.m. Jan. 13, 2014 - Seeking Alpha
6 Biotechnology Stocks to Sell Now 6:30 a.m. Jan. 8, 2014 - InvestorPlace.com
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 8:47 a.m. Jan. 7, 2014 - 247WallSt.com
Protalix BioTherapeutics Appoints Moshe Manor as President and Chief Executive Officer 2:00 a.m. Sept. 29, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:37 a.m. Sept. 4, 2014 - GlobeNewswire
Protalix Announces Conference Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs 5:52 p.m. Aug. 28, 2014 - GlobeNewswire
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Protalix BioTherapeutics Names Shlomo Yanai as Chairman of the Board of Directors 8:01 a.m. July 24, 2014 - GlobeNewswire
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting 7:01 a.m. June 27, 2014 - GlobeNewswire
Protalix BioTherapeutics Initiates Phase II Study With PRX-112, an Orally-Administered Enzyme Replacement Therapy for the Treatment of Gaucher Disease 7:31 a.m. June 18, 2014 - GlobeNewswire
Protalix BioTherapeutics' President and Chief Executive Officer, David Aviezer, Ph.D., Will Retire This Year 8:01 a.m. June 13, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Canada for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:31 a.m. May 30, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences 7:32 a.m. May 28, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Australia for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:32 a.m. May 22, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Oppenheimer 15th Annual Israeli Conference and the MIXiii Israel Innovation Conference, Biomed 7:31 a.m. May 7, 2014 - GlobeNewswire
Protalix Announces Data on Oral antiTNF to be Presented at Digestive Disease Week 2014 Meeting 8:32 a.m. April 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Announces Oral GCD Data to be Presented at WORLD Symposium 2014 8:30 a.m. Feb. 12, 2014 - GlobeNewswire
Protalix BioTherapeutics' Technology Transfer Agreement for UPLYSO(TM) (alfataliglicerase) With Brazil's Ministry of Health Approved by the Brazilian National Institute of Industrial Property 8:30 a.m. Feb. 6, 2014 - GlobeNewswire
Protalix Announces Successful Manufacturing Facility Evaluation by Health Canada 5:30 p.m. Jan. 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Provides Full-Year 2014 Strategic Outlook 8:30 a.m. Jan. 13, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Jan. 7, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Oppenheimer's 24th Annual Healthcare Conference 10:00 a.m. Dec. 3, 2013 - GlobeNewswire
Protalix BioTherapeutics to Present at Upcoming Scientific and Medical Meetings 10:10 a.m. Oct. 31, 2013 - GlobeNewswire
In focus: Awaiting the next move 8:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Using Plants to Make Cheaper Biotech Drugs 10:41 a.m. July 9, 2012 - MarketWatch
Wells Fargo cuts Protalix to market perform 9:11 a.m. June 25, 2012 - Greg Morcroft
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
Wednesday’s biggest gaining and declining stocks 4:47 p.m. May 2, 2012 - MarketWatch
Protalix, Formfactor, Opentable see options volume surge 12:20 p.m. May 2, 2012 - blogs.marketwatch.com
Canaccord cuts Protalix to hold from buy 9:17 a.m. May 2, 2012 - Greg Morcroft
Genworth rises, Chesapeake falls after hours 5:24 p.m. May 1, 2012 - Myra P. Saefong
American Capital options volume surges 10:48 a.m. May 1, 2012 - blogs.marketwatch.com
Protalix prices shares at 14% discount 11:51 a.m. Feb. 16, 2012 - MarketWatch.com
Tuesday’s biggest gaining & declining stocks 5:48 p.m. Dec. 6, 2011 - Kate Gibson
Protalix shares riae 4.6% in preopen trade 8:58 a.m. Aug. 17, 2011 - Greg Morcroft
FDA accepts Protalix resubmission for Gaucher drug 8:57 a.m. Aug. 17, 2011 - MarketWatch.com
Israel stocks lower; Ness agrees to takeover 8:56 a.m. June 12, 2011 - Robert Daniel
Israel stocks fall after central bank’s rate hike 9:12 a.m. May 24, 2011 - Robert Daniel
Israel stocks edge higher, lifted by energy sector 11:12 a.m. May 19, 2011 - Robert Daniel
Israel stocks advance, led by finance, property 7:32 a.m. March 21, 2011 - Robert Daniel
Israel up as Strauss, Migdal, Gazit-Globe report 9:20 a.m. March 16, 2011 - Robert Daniel
Israel stocks lower; Prolor and Protalix ease 8:51 a.m. March 6, 2011 - Robert Daniel
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy
Ebola traders need to rest 10:52 a.m. Today - Seeking Alpha
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 8:12 a.m. Oct. 3, 2014 - Seeking Alpha
How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape 8:42 a.m. Sept. 26, 2014 - Zacks.com
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog 3:12 p.m. Sept. 5, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape 9:11 a.m. Aug. 29, 2014 - Zacks.com
InsiderInsights.com Daily Round Up: 8/15/14 3:06 a.m. Aug. 17, 2014 - Seeking Alpha
Facebook Leads 3 High-Volume Young Gun Stock Leaders 6:14 p.m. June 24, 2014 - Investors Business Daily
Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog 6:15 p.m. June 19, 2014 - Zacks.com
Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape 9:25 a.m. June 19, 2014 - Zacks.com
Protalix commences Phase 2a Gaucher trial 9:01 a.m. June 18, 2014 - Seeking Alpha
Protalix chief to retire 9:25 a.m. June 13, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
10-Q: PROTALIX BIOTHERAPEUTICS, INC. 4:36 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Relative Strength Alert For Protalix BioTherapeutics 12:22 p.m. April 25, 2014 - TheStreet.com
Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology 12:33 p.m. Feb. 13, 2014 - Seeking Alpha
24/7 suggests eight biotech trading near $5 with big upside potential 9:25 a.m. Feb. 8, 2014 - Seeking Alpha
Protalix provides 2014 outlook, shares rise 10:07 a.m. Jan. 13, 2014 - Seeking Alpha
6 Biotechnology Stocks to Sell Now 6:30 a.m. Jan. 8, 2014 - InvestorPlace.com
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 8:47 a.m. Jan. 7, 2014 - 247WallSt.com
Protalix BioTherapeutics Appoints Moshe Manor as President and Chief Executive Officer 2:00 a.m. Sept. 29, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:37 a.m. Sept. 4, 2014 - GlobeNewswire
Protalix Announces Conference Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs 5:52 p.m. Aug. 28, 2014 - GlobeNewswire
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Protalix BioTherapeutics Names Shlomo Yanai as Chairman of the Board of Directors 8:01 a.m. July 24, 2014 - GlobeNewswire
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting 7:01 a.m. June 27, 2014 - GlobeNewswire
Protalix BioTherapeutics Initiates Phase II Study With PRX-112, an Orally-Administered Enzyme Replacement Therapy for the Treatment of Gaucher Disease 7:31 a.m. June 18, 2014 - GlobeNewswire
Protalix BioTherapeutics' President and Chief Executive Officer, David Aviezer, Ph.D., Will Retire This Year 8:01 a.m. June 13, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Canada for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:31 a.m. May 30, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences 7:32 a.m. May 28, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Australia for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:32 a.m. May 22, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Oppenheimer 15th Annual Israeli Conference and the MIXiii Israel Innovation Conference, Biomed 7:31 a.m. May 7, 2014 - GlobeNewswire
Protalix Announces Data on Oral antiTNF to be Presented at Digestive Disease Week 2014 Meeting 8:32 a.m. April 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Announces Oral GCD Data to be Presented at WORLD Symposium 2014 8:30 a.m. Feb. 12, 2014 - GlobeNewswire
Protalix BioTherapeutics' Technology Transfer Agreement for UPLYSO(TM) (alfataliglicerase) With Brazil's Ministry of Health Approved by the Brazilian National Institute of Industrial Property 8:30 a.m. Feb. 6, 2014 - GlobeNewswire
Protalix Announces Successful Manufacturing Facility Evaluation by Health Canada 5:30 p.m. Jan. 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Provides Full-Year 2014 Strategic Outlook 8:30 a.m. Jan. 13, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Jan. 7, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Oppenheimer's 24th Annual Healthcare Conference 10:00 a.m. Dec. 3, 2013 - GlobeNewswire
Protalix BioTherapeutics to Present at Upcoming Scientific and Medical Meetings 10:10 a.m. Oct. 31, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼